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Abstract 
Dementia is a group of symptoms related to memory loss and overall cognitive impairment 
(American Speech-Language-Hearing Association, 2016). Of all of the etiologies of dementia, 
Alzheimer's ranks as the most common, accounting for up to 70% of cases (American Speech-
Language-Hearing Association, 2016). While efforts to understand and treat this disease 
continues to progress, professionals (e.g., speech-language pathologists) work to create 
appropriate and effective therapy strategies for clients and caregivers. In this study, I look to 
analyze the effectiveness of story retell strategies in moderate Alzheimer's dementia patients. 
Pictello, a story application, provides patients with visual and textual cues to help eliminate 
conversational breakdowns, enhancing the conversation experience for both the speaker and 
listener. This method is supported through evidence that written and picture cues have been 
shown to improve conversations of people with dementia, yet no studies have investigated its use 
on tablets for study retell (Bourgeois, 1990). 
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Meta-analysis 
To carry out this project, substantial background research needed to be conducted. Utilizing 
knowledge learned from previous coursework, I generated a small foundation for the project. I 
found textbooks and articles specifically analyzing the topics of my research, and used them to 
model a plan for clinical studies. With the help of my advisor, Dr. Griffith, I completed the 
appropriate documentation (IRB applications) and drafted other necessary forms (background 
essay, consent/assent forms, recruitment forms, and story retell checklist). While the paperwork 
has been completed, I await IRB approval to conduct the research in my career as a graduate 
student. This project is a display of my passions. I have not found myselfto be so dedicated to 
anything else in my life quite like I am to this pursuit. It was a challenge; I never would have 
conceived a year ago that I would be capable of conducting my own research. I encountered 
numerous writing blocks and late nights studying trying to devise the most useful clinical 
applications for my future clients. Now, in this paper, it all has come together. All of my 
research and knowledge will move forward into practical application with my future clinical 
trials. This paper is meant to inform the reader of the importance of research in dementia within 
the field of speech-language pathology and of the direction in which we can begin that process 
together. 
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The Utilization of Story Retell Strategies by People with Moderate Alzheimer's Dementia 
The American Speech-Language Hearing Association (ASHA) indicates cognition as one 
of the domains of practice of speech-language pathologists (SLPs ). This unique area of expertise 
offers a variety of complex subject matter. Dementia is one of the most common syndromes 
affecting cognition. Dementia results in an acquired global loss of brain function, which is slow 
and insidious in nature and gradually affects every major area (e.g., speech, language, cognition, 
pragmatics, swallowing) of concern of the SLP (Manasco, 20 16). The ability of the SLP to 
construct vital treatment plans for this population requires a detailed understanding of the 
syndrome itself. 
The Latin translation for the term "dementia" is "out of one's mind" (Manasco, 2016). 
The symptoms of the syndrome support the translation, the primary symptom being memory 
loss. Other symptoms include persistent compromises in language, visuospatial skills, 
personality, and cognition (Manasco, 2016). With an estimated 24.3 million people living with 
dementia, the role of the SLP becomes increasingly vital (Manasco, 20 16). 
The role of the SLP in dementia is the assessment and treatment of cognitive and 
communication deficits in addition to the training and counseling of caregivers (Manasco, 2016). 
The relationship between cognition and communication cannot be easily dissected, as effective 
speech and language planning require adequate cognitive ability. Problems in communication, 
therefore, are likely to arise when cognitive abilities are impaired (Manasco, 2016). To be able 
to restore communication in these clients, the SLP must first address the cognitive deficits of 
memory, facial recall, vocabulary, word finding, which are all affected by dementia (Manasco, 
2016). Dementia is the syndrome, but there are a variety of etiologies of dementia. By a 60-80 
percent, the most common is Alzheimer's disease (Alzheimer's Association, 2016; Manasco, 
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2016). Alzheimer's disease is the sixth most common cause of death in the United States. There 
are no known treatments to stop or slow the progression of the disease. Alzheimer's disease, in 
addition to cognitive symptoms, has physical markers that are located in the brain. 
Neurofibrillary tangles, amyloid plaques, and granulovacuolar degeneration are pathologic 
changes that were once only visible during a brain autopsy. Recent developments conducted at 
the University of Pittsburgh now offer a fairly noninvasive test for Alzheimer's disease using a 
combination of radioactive compound and positron emission tomography that can detect and 
diagnose the disease invivo (Manasco, 2016). 
Some of the most valuable information sources for Alzheimer's patients and families are 
available through the Alzheimer's Association and the Alzheimer's Foundation of America. The 
Alzheimer's Foundation of America defines Alzheimer's disease as "a progressive, degenerative 
disorder that attacks the brain's nerve cells, or neurons, resulting in loss of memory, thinking, 
language skills, and behavioral changes" (Alzheimer's Foundation of America, 2016). 
Alzheimer's disease manifests through a variety of symptoms and stages. Moderate Alzheimer's 
dementia, the subject of this research, is the middle, or second, stage of Alzheimer's disease. 
Symptoms within the second stage include periods of disorientation, the worsening 
memory/attention skills, increased personality changes, the desire to wonder, further diminishing 
expressive language skills, bladder control deficits, sleep disturbances, and sundowner syndrome 
(Manasco, 2016). The second stage is remarkable because it is when a patient's symptoms begin 
to affect that person's quality oflife and interactions with others (Manasco, 2016). During the 
moderate stage of Alzheimer's the management of symptoms becomes increasingly more 
important to prolong the individual's transition to the final stage of the disease. 
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Nearly all research in the area of Alzheimer's and dementia treatment in the field of 
speech-language pathology stems from the studies ofMichelle S. Bourgeois, Ph.D., CCC-SLP. 
Dr. Bourgeois's most recent book publication is Memory & Communication Aids for People with 
Dementia, published in 2014. The purpose of the book is to describe the evolving memory 
strategies and aids being researched, as, well as provide therapy guides for clinicians of 
individual's with dementia. Research in the area of memory aids, conducted by Bourgeois and 
colleagues, is responsible for the first empirically validated memory aids for dementia patients. 
Her studies conclude that memory aid wallets and books increased the number of on-topic 
statements of fact during conversation and decreased the number of ambiguous, erroneous, and 
perseverative utterances said during the same conversations. She emphasizes the importance and 
relevancy of memory aids with dementia patients through personal encounters with professional 
caregivers, family, and client interactions (Bourgeois, 2013). 
While Bourgeois' book makes an overwhelming contribution to information on dementia 
and the clinical roles of the SLP with these clients, Bourgeois recognizes the need to explore and 
evaluate the use of memory aids and other written cues for the many unique expressions of 
memory impairment (Bourgeois, 2013). One of the areas that needs more research is the specific 
examination of memory aids and story retell strategies in dementia patients. Due to the 
overwhelming variety of dementias and severities, this study will examine the use of visual and 
textual supports as a memory aid to facilitate story retell with people with moderate Alzheimer's 
dementia. 
Hypothesis 
It is hypothesized that the utilization of the picture and verbal prompt strategies will have 
a positive impact on story retell in Alzheimer's patients by reducing the effects of memory loss 
ALZHEIMER'S DEMENTIA 5 
and increasing the ability to provide sufficient details with minimal conversation breakdowns. 
This hypothesis is consistent with the findings of previous research conducted by Dr. Michelle 
Bourgeois. In her previous research, Dr. Bourgeois concludes that memory aids with written and 
picture cueing effectively improve communication of persons with dementia by reducing the 
effects of memory loss (Bourgeois, 1990). 
Method 
Inclusion/Exclusion Criteria 
Participants of the study are limited to men and women at least 18 years of age with a 
physician's diagnosis of moderate Alzheimer's dementia. There is no ceiling on a maximum age 
for participants. Vision and hearing capabilities need to satisfy requirements for completing the 
therapeutic tasks (i.e., identify pictures, words, and follow one-step commands). Prospective 
participants that cannot satisfy these demands will be excluded from the study to preserve 
fidelity. The number of participants is limited to 3-5 people. 
Recruitment Procedures 
The research team will contact local pathologists and discussing the purpose of the 
research project. The team will ask for referrals of potential participants who may be interested 
in the project. Once potential participants are identified, a member of the research team will 
contact or discuss with the participant and legal guardian (if necessary) the purpose of the project 
and initiate the consent process. If the legal guardian and/or client wish to proceed, the legal 
guardian, legal representative, or the client will sign the appropriate consent forms. 
Assessment Procedures 
The study will be broken down into multiple one-hour sessions. The first session is 
dedicated to participants completing an initial assessment with the primary investigator (PI). 
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This assessment includes a) visual and hearing screening (i.e., dBNU meter to ensure 
appropriate conversation volume is use, b) a standardized cognitive assessment: the Mini Mental 
State Exam-2, c) a client and caregiver interview. The purpose ofthe interviews is to establish a 
personalized story and to gather pictures from the participants' life events. 
Treatment Procedures 
The following sessions will make up the treatment process. The first step of treatment is 
a controlled story training session with the PI. Participants will be asked to identify the "who," 
"what," "when," "where," "why," and "how" of the story. They will participate in compensatory 
strategies, such as utilizing an iPad for visual reinforcement through pictures and text provided 
by the PI. The program will provide auditory reinforcement through simulated reading 
programming and verbal prompting. Participants will be asked to review the strategies with the 
PI and to attempt to retell the story. The participants will engage in a minimum of one and no 
more than three controlled story training sessions. In order to move on in the therapy protocol, 
participants must be able to state all necessary elements of a story retell with no more than ten 
cues. 
The second step of the treatment process is a personalized story training session with the 
PI. The personalized training session will utilize a story from the pasts of the partipants and 
personal pictures gathered during the assessment interviews. Participants will be asked to 
identify the "who " "what " "when " "where " "why " and "how" of the story They will 
' ' ' ' ' . 
participate in compensatory strategies, such as utilizing an iPad for visual reinforcement through 
pictures and text provided by the PI. The program will provide auditory reinforcement through 
simulated reading programming and verbal prompting. Participants will be asked to review the 
strategies with the PI and to attempt to retell the story. The participants will engage in a 
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minimum of one and no more than three personalized story training sessions. In order to move 
on in the therapy protocol, participants must be able to state all necessary elements of a story 
retell with no more than ten cues. 
The third and final step of the treatment process is a personalized story-retell session with 
a novel listener who will be trained by the research team. The research listener will be trained 
and will be restricted to asking clarifying questions or provide comments to topics initiated by 
the participant. Following the interaction with the research participant, the research listener will 
undergo an interview with the PI to determine if all necessary elements were present in the 
participants' story. 
Analysis 
The final personalized story retell session will be recorded in its entirety. The video will 
be transcribed verbatim, and the transcripts will be coded for the following dependent measures: 
description, prompting, and conversation breakdowns. 
Discussion 
Limitations 
This study provides information pertinent to clinical practice of the SLP with moderate 
Alzheimer's patients but is limited its exploratory nature. Without more testing and research, the 
strategies presented will not have a solid foundation of empirical evidence for evidence-based 
practice. Another limitation is that this investigation examines the effects of specific 
intervention strategies on moderate Alzheimer's dementia patients, and it does not generalize to 
other levels of Alzheimer's severity. By limiting the group to this specific stage of the disease, 
discrepancies in treatment procedure reliability, validity and flexibility are affected. Also, the 
results of the study reflect the specific treatment procedures utilized in the training sessions. 
ALZHEIMER'S DEMENTIA 8 
Deviation from the procedural protocol may cause discrepancies in results. Additionally, this 
study limits itself to eight days maximum with each client, which may not be enough time to 
provide evidence that the strategies in this research trial maintain over time. The population size 
of this study is significantly smaller than other clinical research studies. By limiting population 
size to 3-5 participants, generalization to a larger population is not proven. Further research 
needs to be conducted to further test the validity and reliability of this study for the overall 
population of moderate Alzheimer's patients, rather than just the few participants of the study. 
Research Implications 
As this is an exploratory study, new research information will be added to the database of 
the role of the SLP with Alzheimer's patients. Regardless of the level of effectiveness of the 
strategies utilized in this study, this new information will direct future research in the area of 
Alzheimer's and story-retell. Furthermore, future research could examine the ability of 
participants and caregivers to troubleshoot systems used in this study. 
Clinical Implications 
Should the study conclude that these strategies are not effective, clinicians will have 
evidence that this process is not productive for future clients. If the study concludes that these 
strategies are effective, clinicians will have another treatment strategy to implement with 
moderate Alzheimer's dementia clients. Foreseen advantages of this form of communication aid 
are the adaptability and simple interface of the technology, personalization, and the vast variety 
of applications that can work with the user for numerous daily communication functions (e.g., 
story telling, communicating wants and needs, etc . .. ) 
Quality of Life 
In the article Supporting Narrative Retells for People With Aphasia Using Augmentative 
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and Alternative Communication: Photographs or Line Drawings? Text or No Text? evidence 
suggests that visual and linguistic supports improved story retell in participants with aphasia 
(Griffith, Dietz, & Weissling, 2014). Improved story retell was also found in the The Impact of 
Interface Design During an Initial High-Technology AAC Experience: A Collective Case Study 
of People with Aphasia, as the authors note that the time that participants in the study spent on 
off-topic commentary during story retells decreased with the use of augmentative and alternative 
communication (ACC) devices (Dietz, et al., 2014). Bourgeois mentions in her book that 
memory aids promote social interaction of nursing home residents between volunteers, other 
residents, and the nursing staff, providing benefits for all involved (Bourgeois, 2013) 
Consistently, previous research provides evidence for improved quality of life (QoL) of patients 
through the use of memory aids in conversation, yet it is unclear if the results are generalizable to 
dementia patients. 
Conclusion 
There is a limited supply of research in the field of speech-language pathology on 
dementia. Since Alzheimer's disease is the leading cause of dementia and reaching epidemic 
levels, it should be an area of immediate concern to SLPs. While there is some valuable research 
available to practicing clinicians, specific research on story-retell strategies for Alzheimer's 
patients is lacking. This study understands the need for information for current and future 
researchers and clinicians. The results of this investigation will provide clinicians with more 
information and will help to guide future research. 
The field of speech-language pathology is undoubtedly one in a constant state of change. 
The evolution of research, clinical practice, and education in the field proves to make dramatic 
gains in client successes. Providing more information on the field and distributing this 
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knowledge benefits not only professionals in the field, but also society as a whole. Opening the 
lines for better communication between all members of society is essential to the state of the 
future. 
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Kramer: The Utilization of Story Retell Strategies by People with Moderate Alzheimer's 
Dementia 
Recruitment Form 
Hello, I am seeking participants for a clinical study to investigate the effectiveness of story retell 
strategies in persons with moderate Alzheimer's dementia. The study should take no more than 
three to seven sessions to complete. 
To participate in the study, you must be at least 18 years of age and have sufficient hearing and 
visual abilities. Your participation in this study is completely voluntary. Your responses will be 
used solely for research purposes. All data will be collected anonymously and will be saved on a 
password-protected computers and servers. 
If you're interested in participating, please contact the primary investigator of the study, Ashleigh 
Kramer, at 812-614-4347. 
If you have any questions about this study or your ability to participate, please contact Julie 
Griffith by email: jgriffith2@bsu.edu. Your time and participation is greatly appreciated. 
Thank you. 
Ashleigh Kramer & Julie Griffith, Ph.D. CCC-SLP 
IHP. PriYa · Auth rizati n Form 
1d dis 
m: 
• R 
I authoriz 
re adng om n I h I 
h I dru~ abu · 
oriz;a o 
n c Po 1hf)· an 
o m com I he lth 
municabte diseases, HI 
:c1R. 
ation 
ord m luding ,. 
r AI d tr ann 0 
l authonze e r I sc f m • com I h al r cord \\1th e exce on 
" g I f rmah n; 
mw icabJe dise ndudin UI I and m } 
a bus 
o e~e 
I mformatton m · b 
edical treatm tor 
b the pe n l u or·2 
I tall on, llmg r clai 
rc a d l" 
res. 
unul ______ .(dat 
t. enrollm n , or ·h iblhly 
gn his au onT.atto 
pursuan this 
r d may no Inn r pr b • 
Consent Form 
Kramer: An Examination of Communication Rehabilitation in Moderate Alzheimer's Dementia 
Study Purpose and Rationale 
The purpose of this study is to determine the effectiveness of story-retell strategies as a memory aid for Alzheimer's 
patients. Specifically this investigation will examine the influence of pictures and verbal prompts on the ability of 
Alzheimer's patients to provide story details without communicative breakdowns. We hypothesize that the utilization of the 
picture and verbal prompt strategies will have a positive impact on story-retell in Alzheimer's patients by reducing the 
effects of memory loss. 
Inclusion/Exclusion Criteria 
Participants must be adult men and women with moderate Alzheimer's dementia. Vision and hearing capabilities must 
satisfy requirements for completing the therapeutic tasks (i.e. identify pictures and words and follow one-step commands). 
Participation Procedures and Duration 
Assessment: 
Participants complete an initial assessment, including a visual and hearing screening. Participants will complete 
two standardized assessments: the Mini Mental State Exam-2 and the Dementia Rating Scales-2. Client/family 
interviewing will be conducted to establish a personalized story and to gather pictures from the client's life events. 
Treatment 
a. Selected participants will go through a controlled story training session with the primary investigator. 
Participants will be asked to identify the "who," "what," "when," "where," and "why" of the story. They will utilize an 
iPad for visual reinforcement through pictures provided by the primary investigator. The app will allow participants 
aid in retelling the story. Participants will be asked to review the therapy with the primary investigator and to 
attempt to retell the story to the primary investigator. This controlled story training will be a minimum of one 
session and no more than three sessions. In order to move on in the therapy protocol, participants must be able 
to state all necessary elements of a story retell with no more than moderate cues. 
b. Participants will go through a personalized story training session with primary investigator. Participants will be 
asked to identify the "who, " "what," "when," "where," and "why" of the story. They will utilize an iPad for visual 
reinforcement through pictures provided by the primary investigator. The app will allow participants aid in retelling 
the story. Participants will be asked to review the therapy with the primary investigator and to attempt to retell the 
story to the primary investigator. This personalized story training will be a minimum of one session and no more 
than three sessions. In order to move on in the therapy protocol, participants must be able to state all necessary 
elements of a story retell with no more than moderate cues. 
c. Participants will retell the personalized story to a nove/listener who will be trained by the research team. The 
research listener will be trained to be a conversational partner who will be restricted to asking clarifying questions 
or providing comments to topics initiated by the participant. Following the interaction with the research participant, 
the research listener will undergo an interview with the primary investigator to determine if all necessary elements 
were present in the participant's story. The primary investigator will evaluate the number of conversational 
breakdowns and prompts, along with the effectiveness of the provided strategies. 
Audio or Video Recordings (if applicable) 
Video recordings will be included in this study. Each treatment session will be recorded to provide the primary investigator 
more time to review participant responses for a higher level of accuracy. These recordings will be stored on a private 
server in a locked room and will be deleted along with other participant information after a 3-5 year time period. Only 
members of the research team will have access to these recordings. 
Disclosure of Alternative Procedures 
There are no alternative procedures for this study. 
Data Confidentiality or Anonymity 
All data will be maintained as confidential (if collecting identifiable data, i.e, audio/video recordings and no identifying 
information such as names will appear in any publication or presentation of the data. 
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Storage of Data and Data Retention Period 
Information will be obtained from medical records, specifically date of birth for standardized assessment purposes. Name 
and phone number will be collected for contact purposes, such as making follow-up appointments. Video recordings will 
be made of all the treatment sessions. All identifiable information will be stored on HIPAA compliant servers in a locked 
office and will only be accessible to the research team. 
Risks or Discomforts 
There are no perceived risks for participating in this study. 
Who to Contact Should You Experience Any Negative Effects from Participating in this Study 
If you should experience any negative effects from participating in this study, please contact the primary investigator, 
Ashleigh Kramer, at 812-614-4347 or Neuropsychology of Indiana at 317-672-0541. 
Benefits 
Patients may have an increase in cognitive communication skills necessary for story retelling. 
Voluntary Participation 
"Your participation in this study is completely voluntary and you are free to withdraw your permission at anytime 
for any reason without penalty or prejudice from the investigator. Please feel free to ask any questions of the 
investigator before signing this form and at any time during the study." 
IRB Contact Information 
For one's rights as a research subject, you may contact the following: For questions about your rights as a research 
subject, please contact the Director, Office of Research Integrity, Ball State University, Muncie, IN 47306, (765) 285-5070 
or at irb@bsu.edu. 
An Examination of Communication Rehabilitation in Moderate Alzheimer's Dementia 
********** 
Consent 
I, , agree to participate in this research project entitled, An Examination of Communication 
Rehabilitation in Moderate Alzheimer's Dementia. I have had the study explained to me and my questions have been 
answered to my satisfaction. I have read the description of this project and give my consent to participate. I understand 
that I will receive a copy of this informed consent form to keep for future reference. 
To the best of my knowledge, I meet the inclusion/exclusion criteria for participation (described on the previous page) in 
this study. 
Participant's Signature 
Researcher Contact Information 
Principal Investigator: 
Ashleigh Kramer, Graduate Student 
Speech-language Pathology 
Ball State University 
Muncie, IN 4 7306 
Telephone: (812) 614-4347 
Email: akkramer@bsu.edu 
Date Last Updated: 12/1 4/2016 
Date 
Faculty Supervisor: 
Dr. Julie Griffith 
Speech-language Pathology 
Ball State University 
Muncie, IN 47306 
Telephone: (765) 285-8177 
Email: jgriffith2@bsu.edu 
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Kramer: The Utilization of Story Retell Strategies by People with Moderate 
Alzheimer's Dementia 
Assent Form 
My name is Ashleigh Kramer. I am trying to learn about moderate Alzheimer's dementia. 
I want to investigate what story-retell strategies are most effective for everyday 
communication. If you would like, you can be in my study. 
If you decide you want to be in my study, you will have your vision and hearing screened 
and take a cognitive test. You will also complete three to seven days of treatment, where 
you will tell stories using an iPad. On the last day of treatment, you will tell a story to 
someone new. 
There are no perceived risks for participating in this study. By participating in this study, 
you may be a better story reteller. 
Other people will not know if you are in my study. I will put things I learn about you 
together with things I learn about other Alzheimer patients. When I tell other people 
about my research, I will not use your name, so no one can tell I'm talking about you. 
Your legal representative has to say it's OK for you to be in the study. After they decide, 
you get to choose if you want to do it too. If you don't want to be in the study, no one 
will be mad at you. If you want to be in the study now and change your mind later, that's 
OK. You can stop at any time. 
My telephone number is 812-614-4347. You can call me ifyou have questions about the 
study or if you decide you don't want to be in the study any more. 
I will give you a copy of this form in case you want to ask questions later. 
Agreement 
I have decided to be in the study even though I know that I don't have to do it. Ashleigh 
Kramer has answered all my questions. 
Signature of Study Participant Date 
Signature of Researcher Date 
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